Persistent Clinical Response of Infliximab Therapy in Patients with Refractory Rheumatoid Arthritis, over a 3-Year Period

Publisher： Bentham Science Publishers

E-ISSN： 2212-3938|1|1|103-108

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.1, Iss.1, 2006-01, pp. : 103-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Infliximab: Exacerbation of rheumatoid arthritis: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1133, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Etanercept appears to be effective for patients with rheumatoid arthritis (RA) who fail to achieve or maintain an adequate response to infliximab

By  

Inpharma, Vol. 1, Iss. 1615, 2007-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Early changes in bone metabolism in rheumatoid arthritis patients treated with infliximab

By  

Arthritis & Rheumatism, Vol. 48, Iss. 10, 2003-10 ,pp. : 2996-2997

John Wiley & Sons Inc

Access to resources Recommend Favorite

Durability and Rapidity of Response to Anakinra in Patients with Rheumatoid Arthritis

By Michael H. Schiff  

Drugs, Vol. 64, Iss. 22, 2004-01 ,pp. : 2493-2501

Adis International

Access to resources Recommend Favorite

Adalimumab is an effective option in the treatment of patients with refractory rheumatoid arthritis

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 4, 2005-04 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite